Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][3]. Group 1: Class Action Details - Investors who bought LifeMD securities between May 7, 2025, and August 5, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 27, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements, including being ranked No. 1 for securities class action settlements in 2017 and recovering over $438 million for investors in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that LifeMD's defendants made materially false and misleading statements regarding the company's competitive position and financial guidance, particularly concerning customer acquisition costs [5]. - It is claimed that these misrepresentations led to investor damages when the true information became public [5].

Core Viewpoint - A class action securities lawsuit has been filed against RCI Hospitality Holdings, Inc. alleging securities fraud affecting investors between December 15, 2021, and September 16, 2025 [1][2]. Group 1: Lawsuit Details - The complaint claims that defendants engaged in tax fraud and bribery to conceal this fraud, leading to an understatement of legal risks for the company [2]. - Defendants' statements regarding the company's business, operations, and prospects were allegedly materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 20, 2025, to request appointment as lead plaintiff, although participation does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Points - Faruqi & Faruqi, LLP is investigating potential claims against KBR, Inc. related to losses suffered by investors between May 6, 2025, and June 19, 2025, with a deadline of November 18, 2025, to seek lead plaintiff status in a federal securities class action [1][2] - The complaint alleges that KBR and its executives made false and misleading statements regarding the Global Household Goods Contract with the U.S. Department of Defense, leading to investor damages when the truth was revealed [2][3] Company Overview - KBR, Inc. is facing legal scrutiny due to allegations of violating federal securities laws, specifically concerning misleading statements about its partnership with HomeSafe and the status of the Global Household Goods Contract [2][3] - Following the announcement of the termination of the Global Household Goods Contract, KBR's stock price experienced a significant decline, dropping $3.85 (7.29%) to $48.93 on June 20, 2025, and a further $1.30 (2.65%) to $47.63 on June 23, 2025 [3] Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, and any member of the class can move to serve as lead plaintiff [4] - Faruqi & Faruqi encourages individuals with information regarding KBR's conduct, including whistleblowers and former employees, to come forward [4]

Core Points - The law firm Faruqi & Faruqi, LLP is investigating potential claims against V.F. Corporation (VFC) for alleged violations of federal securities laws, specifically regarding misleading statements about the company's turnaround plans and the Vans brand's revenue growth trajectory [2][3] - A federal securities class action has been filed against VFC, with a deadline of November 12, 2025, for investors to seek the role of lead plaintiff [1][4] - Following the disclosure of significant declines in Vans' growth, VFC's stock price dropped approximately 15.8% in one day, from $14.43 to $12.15 per share [3] Company Overview - V.F. Corporation is facing scrutiny for its handling of the Vans brand, which has reportedly experienced a decline in revenue growth, with losses worsening from 8% to 20% in the fourth quarter of fiscal 2025 [3] - The company attributed its poor performance to deliberate actions taken to eliminate unprofitable businesses, which were not previously disclosed to investors [3] Legal Context - The lead plaintiff in the class action will be the investor with the largest financial interest who is also typical of the class members, and any member can move to serve as lead plaintiff or remain an absent class member [4] - Faruqi & Faruqi encourages individuals with information regarding VFC's conduct to come forward, including whistleblowers and former employees [4]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quantum Corporation To Contact Him Directly To Discuss Their Options If you suffered losses in Quantum Corporation between November 15, 2024 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) - ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you suffered losses in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading nation ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Tronox Holdings plc due to significant financial losses and misleading statements made by the company regarding its performance and market conditions [3][5]. Group 1: Financial Performance and Decline - Tronox announced a significant reduction in TiO2 sales for Q2 2025, attributing the decline to a softer coatings season and increased competition [6]. - Following the announcement, Tronox revised its 2025 financial outlook, lowering full-year revenue guidance and reducing its dividend by 60% [6]. - The company's stock price fell dramatically from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in one day [7]. Group 2: Legal Actions and Investor Rights - A federal securities class action has been filed against Tronox, with a deadline of November 3, 2025, for investors to seek the role of lead plaintiff [3]. - The complaint alleges that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and forecasting processes [5]. - Faruqi & Faruqi encourages anyone with information regarding Tronox's conduct to come forward, including whistleblowers and former employees [9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against LifeMD, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements and financial guidance [3][4]. Group 1: Allegations Against LifeMD - The complaint alleges that LifeMD and its executives materially overstated the company's competitive position [3]. - It is claimed that the executives were reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in the RexMD segment and related to obesity treatment drugs [3]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [3]. Group 2: Financial Impact - On August 5, 2025, LifeMD reported its second-quarter financial results, revising its revenue guidance to a range of $250 to $255 million, down from the previous guidance of $268 to $275 million [4]. - Following this announcement, LifeMD's stock experienced a significant decline of 44.8% on August 6, 2025 [4]. Group 3: Legal Proceedings - There is a deadline of October 27, 2025, for investors to seek the role of lead plaintiff in the federal securities class action against LifeMD [1]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered losses in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans and illegal kickbacks [3][5][6] Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [5] - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans [5] - SelectQuote allegedly received illegal kickbacks from health insurers to steer beneficiaries towards certain plans, limiting enrollment in competitors' offerings [5] - The company is accused of violating federal laws, including the False Claims Act, due to its conduct [5][6] - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021 [6] Group 2: Impact on Stock and Legal Proceedings - Following the DOJ's allegations, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6] - Investors are reminded of the October 10, 2025 deadline to seek the role of lead plaintiff in the federal securities class action against SelectQuote [3][7]